Clinical Trial Update: Activated Protein C in Severe Acute Pancreatitis [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating activated protein C for severe acute pancreatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatitis

Drugs mentioned

• Xigris (Drotrecogin alfa (activated))

Snippet

Sponsor: Helsinki University Central Hospital | Conditions: Acute Pancreatitis | Phase 4 | Status: COMPLETED